(ALS, Charcot, Lou Gehrig)
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability
Main results: Treatment of MS patients with Sativex(®) does not negatively impact on driving ability and may improve moderate to ...
Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
Main results: In general, cognitive performance declined mostly in a THC dose-dependent manner, with steady resolution of impairment in the ...
Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a tobacco substitute
Main results: All urine samples tested negative by three immunochemical assays for detection of cannabis use. This is an important ...
Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability
Main results: No significant impact on driving ability was found after smoking CBD-rich marijuana. No effects on vital signs were ...
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Main results: Cannabis containing equivalent concentrations of CBD and THC appears no less impairing than THC-dominant cannabis, and in some ...
Orally administered cannabidiol (CBD) does not produce false‐positive tests for THC on the Securetec DrugWipe® 5S or Dräger Drug Test® 5000
Main results: Orally administered CBD does not appear to produce false-positive (or true-positive) tests for THC on the DW-5S and ...
Simulated driving performance among daily and occasional cannabis users
Main results: Occasional users had a similar drug effect as daily users but lower blood THC. Smoked cannabis led to ...
Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Main results: Most driving-related skills are predicted to recover within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg Δ9-THC ...
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Main results: we highlight the possibility that, in addition to neurons, glial changes could help to explain the complex pharmacology ...
Diversity of molecular targets and signaling pathways for CBD
Main results: CBD’s potential as a therapeutic comes from its multiple mechanisms of action. This wide range of pharmacological activity ...
